Hidekazu Tomimoto - Neurology

Author Information

Hidekazu Tomimoto is a distinguished researcher affiliated with the Department of Neurology at Mie University Graduate School of Medicine, Faculty of Medicine, located in Mie, Japan. His extensive work in the field of neurology has contributed significantly to the understanding of various neurological conditions and treatment approaches, enhancing both academic research and clinical practices.

Research Contributions

Hidekazu Tomimoto has made substantial contributions to the field of neurology, with a focus on cerebrovascular diseases, cognitive dysfunction, and neurodegenerative disorders. His recent studies include investigating the impact of hypertension and advanced age on cognitive impairment following mild traumatic brain injuries, exploring the expression of amyloid precursor proteins in endothelial cells, and examining the risks associated with cerebral microbleeds post-ablation therapy in patients with atrial fibrillation. Furthermore, he has researched the implications of brain edema following deep brain stimulation surgery and has contributed to the understanding of dual antiplatelet therapy in stroke patients. His work is pivotal in elucidating the mechanisms underlying neurological disorders and informing therapeutic strategies.

Aliases

Hidekazu Tomimoto is also known by several aliases, including H Tomimoto and H. Tomimoto. These variations are often used in academic and professional publications.

Publication and Citation Metrics

Metric	Value
Citation Count	9100
H-index	55
Paper Count	434

Publications:

Hypertension and advanced age increase the risk of cognitive impairment after mild traumatic brain injury: A registry-based study.

DOI: 10.1016/j.wneu.2022.03.010

Year: 2022

Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice.

DOI: 10.1016/j.jbc.2022.101880

Year: 2022

Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy

DOI: 10.3389/fncel.2022.818288

Year: 2022

Relationship of brain edema after deep brain stimulation surgery with motor and cognitive function

DOI: 10.1016/j.heliyon.2022.e08900

Year: 2022

Deep Brain Stimulation in a Patient with Parkinson's Disease and Cortical Superficial Siderosis.

DOI: 10.2169/internalmedicine.9253-21

Year: 2022

Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis

DOI: 10.1038/s41440-022-00862-y

Year: 2022

Evaluation of cortical superficial siderosis in patients with cognitive dysfunction using 3D FLAIR and 3D DIR

DOI: 10.1007/s00330-021-07751-x

Year: 2021

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel

DOI: 10.1161/STROKEAHA.121.034378

Year: 2021

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis

DOI: 10.1161/JAHA.121.022575

Year: 2021

Prevalence and risk factors for brain white matter changes in young and middle-aged participants with Brain Dock (brain screening): a registry database study and literature review

DOI: 10.18632/aging.202933

Year: 2021

What are the Diagnostic Methods for Detecting LRRK2 Mutations?

How is PRMS Different from Other Forms of MS?

What is the Prognosis for CFS Patients?

What Are the Challenges?

What is Parkinson's Disease?

What is the LRRK2 Gene?

What are the Benefits and Limitations of Genetic Testing?

Can Numbness and Tingling Be Prevented?

What are the treatment options for neurological vision problems?

What Diagnostic Tools Are Used in Neurology?

Partnered Content Networks

Relevant Topics